rs571906190
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4BP6BS2
The NM_005379.4(MYO1A):c.1667C>T(p.Ser556Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000365 in 1,614,238 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005379.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO1A | NM_005379.4 | c.1667C>T | p.Ser556Phe | missense_variant | Exon 17 of 28 | ENST00000300119.8 | NP_005370.1 | |
MYO1A | NM_001256041.2 | c.1667C>T | p.Ser556Phe | missense_variant | Exon 18 of 29 | NP_001242970.1 | ||
MYO1A | XM_047428876.1 | c.1667C>T | p.Ser556Phe | missense_variant | Exon 18 of 29 | XP_047284832.1 | ||
MYO1A | XM_011538373.3 | c.1667C>T | p.Ser556Phe | missense_variant | Exon 17 of 25 | XP_011536675.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO1A | ENST00000300119.8 | c.1667C>T | p.Ser556Phe | missense_variant | Exon 17 of 28 | 1 | NM_005379.4 | ENSP00000300119.3 | ||
MYO1A | ENST00000442789.6 | c.1667C>T | p.Ser556Phe | missense_variant | Exon 18 of 29 | 1 | ENSP00000393392.2 | |||
MYO1A | ENST00000476795.1 | n.564C>T | non_coding_transcript_exon_variant | Exon 3 of 3 | 5 | |||||
MYO1A | ENST00000554234.5 | n.1181C>T | non_coding_transcript_exon_variant | Exon 13 of 24 | 5 | ENSP00000451033.1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251362Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135844
GnomAD4 exome AF: 0.0000150 AC: 22AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727246
GnomAD4 genome AF: 0.000243 AC: 37AN: 152346Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:2
The c.1667C>T (p.S556F) alteration is located in exon 17 (coding exon 16) of the MYO1A gene. This alteration results from a C to T substitution at nucleotide position 1667, causing the serine (S) at amino acid position 556 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
The Ser556Phe variant in MYO1A has not been previously reported in individuals w ith hearing loss and was absent from large population studies. Computational pr ediction tools and conservation analyses do not provide strong support for or ag ainst an impact to the protein. In summary, the clinical significance of the Ser 556Phe variant is uncertain. -
not provided Benign:1
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at